Press Releases

• Purchase price of approximately $8.1 million • Acquisition increases PharmaCorp’s operating network to 15 pharmacies • Previously announced second definitive share purchase agreement has received preliminary college approval and is anticipated to close on or about August 17, 2026 • Additional non-binding letter of intent executed for a proposed pharmacy acquisition in Western Canada

Anchored in the 2026 global campaign’s core mission of early detection, equitable access to screening, and compassionate patient support, BioMark advances its multi-marker liquid biopsy to ensure no patient is left behind.